- Home
- NVGS vs NEO Comparison
NVGS vs NEO Comparison
Compare NVGS & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVGS | NEO |
|---|---|---|
| Founded | 1997 | 2001 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | NVGS | NEO |
|---|---|---|
| Price | $17.18 | $12.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $21.50 | $11.38 |
| AVG Volume (30 Days) | 279.9K | ★ 1.6M |
| Earning Date | 11-04-2025 | 10-28-2025 |
| Dividend Yield | ★ 1.63% | N/A |
| EPS Growth | ★ 33.99 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | $578,158,000.00 | ★ $709,162,000.00 |
| Revenue This Year | $2.77 | $10.87 |
| Revenue Next Year | N/A | $9.84 |
| P/E Ratio | $11.46 | ★ N/A |
| Revenue Growth | 2.46 | ★ 10.10 |
| 52 Week Low | $10.55 | $4.72 |
| 52 Week High | $18.29 | $19.12 |
Technical Indicators
Market Signals| Indicator | NVGS | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 46.36 | 63.31 |
| Support Level | $17.19 | $12.18 |
| Resistance Level | $17.47 | $12.63 |
| Average True Range (ATR) | 0.25 | 0.39 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 10.53 | 70.94 |
Price Performance
Historical ComparisonAbout NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.